Back to Trades
Total Value
$1.6K
Net $1.6K bought
Filing Date
Jul 17, 2026
1 transaction
Purchases
$1.6K
1 transaction
Trade Summary
On Jul 15, 2026, ADAR1 Capital Management, LLC, 10% Owner, purchased $1.6K of InMed Pharmaceuticals Inc. (INM) across 1 transaction. The filing covers Common Shares and reflects net buying of $1.6K. Reported prices ranged from $1.55. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- InMed Pharmaceuticals Inc.
- Ticker Symbol
- INM
- CIK
- 0001728328
Insider Information
- Role
- 10% Owner
- Location
- AUSTIN, TX
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 15, 2026
- Accession Number
- 0001940272-26-000010
- Form Type
- 4
- Net Trading Amount
- $1.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | Common Shares | 1,000 | $1.55 | Purchase | $1.6K |
Want live alerts when ADAR1 Capital Management, LLC trades again?
Download Insider Trades to track INM, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
- (F2)For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.